Two Former Accutane Users Win $18 Million Verdict

A jury in New Jersey late Friday returned an $ 18 million verdict to two former Accutane users against Nutley, N.J.-based pharmaceutical companies Hoffmann La-Roche Inc. and Roche Laboratories, subsidiaries of Roche Holding AG (ROG).

(Press Release Distribution) A jury in New Jersey late Friday returned an $ 18 million verdict to two former Accutane users against Nutley, N.J.-based pharmaceutical companies Hoffmann La-Roche Inc. and Roche Laboratories, subsidiaries of Roche Holding AG (ROG). The plaintiffs, Katie Rossitto and Riley Wilkinson, took Accutane for treatment of their acne in the 1990s and developed ulcerative colitis-a debilitating, permanent disease-as a result. Each was awarded $ 9 million in compensatory damages for the injuries caused by their use of Accutane. Lead counsel for plaintiffs in the consolidated trial were David Buchanan of Seeger Weiss LLP (New Jersey/New York) and Troy Rafferty of Levin Papantonio, PA (Pensacola).

In response to the verdict, Mr. Buchanan stated: "We’re extremely pleased for Katie and Riley. They’ve suffered greatly at the hands of Roche’s drug, and the jury’s verdict provides a measure of justice for each of them.” Buchanan added, “The evidence revealed that Roche withheld its knowledge and conclusions about the risk of inflammatory bowel disease from doctors prescribing the drug, and thus patients, like Ms. Rossitto and Mr. Wilkinson, were completely unaware of the risks of this debilitating disease.”

Ms. Rossitto and Mr. Wilkinson’s cases were tried together with….

Click the link to obtain more details on Seeger Weiss LLP

Latest Press Releases and News From I-Newswire.com